SeaStar Medical Holding Corp (ICU) USD0.0001
Sell:$1.24Buy:$1.29
$0.02
(1.56%)
- This stock can be held in a
Stocks and Shares ISA$0.02
(1.56%)$0.02
(1.56%)Company Information
About this company
SeaStar Medical Holding Corporation is a commercial-stage medical technology company, which is focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. It has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).
Key people
Key facts
- EPICICU
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- ISINUS81256L2034
- Market cap$10.90m
- Employees19
- Shares in issue9.80m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.